NEW YORK (GenomeWeb News) – Geneva Bioinformatics will distribute Protagen’s Modiro, a software tool for rapid and automated detection of post-translational modifications in MS/MS datasets, the firms said in a joint statement today.
Under terms of the alliance, GeneBio will distribute the Modiro product on a global basis. The firms also intend to collaborate in linking the Modiro functionalities to GeneBio’s Pehnyx software platform for mass spectrometry data analysis.
“We are well aware of the reputation of both GeneBio and Phenyx within the industry and feel that our combined efforts will help to establish Modiro as the gold-standard for PTM analysis,” Christoph Hüls, CEO of Dortmund, Germany-based Protagen, said in a statement.
Further terms of the agreement were not disclosed.